XML 45 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements (Tables)
12 Months Ended
May 31, 2017
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company's financial assets and liabilities measured at fair value on a recurring basis as of May 31, 2017 and 2016, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. Refer to Note 1 — Summary of Significant Accounting Policies for additional detail regarding the Company’s fair value measurement methodology.
 
 
As of May 31, 2017
(In millions)
 
Assets at Fair Value
 
Cash Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
505

 
$
505

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,545

 
159

 
1,386

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
813

 
769

 
44

 

U.S. Agency securities
 
522

 
150

 
372

 

Commercial paper and bonds
 
820

 
251

 
569

 

Money market funds
 
1,974

 
1,974

 

 

Total level 2
 
4,129

 
3,144

 
985

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
10

 

 

 
10

TOTAL
 
$
6,189

 
$
3,808

 
$
2,371

 
$
10

 
 
 
As of May 31, 2016
(In millions)
 
Assets at Fair Value
 
Cash Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
774

 
$
774

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,265

 
100

 
1,165

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
831

 
827

 
4

 

U.S. Agency securities
 
679

 

 
679

 

Commercial paper and bonds
 
733

 
262

 
471

 

Money market funds
 
1,175

 
1,175

 

 

Total level 2
 
3,418

 
2,264

 
1,154

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
10

 

 

 
10

TOTAL
 
$
5,467

 
$
3,138

 
$
2,319

 
$
10


Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of May 31, 2017 and 2016, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of May 31, 2017
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
231

 
$
216

 
$
15

 
$
246

 
$
166

 
$
80

Embedded derivatives
 
10

 
1

 
9

 
8

 
2

 
6

Interest rate swaps
 

 

 

 

 

 

TOTAL
 
$
241

 
$
217

 
$
24

 
$
254

 
$
168

 
$
86

(1)
If the foreign exchange derivative instruments had been netted in the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $187 million as of May 31, 2017. As of that date, no amount of cash collateral had been received or posted on the derivative asset and liability balances related to these foreign exchange derivative instruments.
 
 
As of May 31, 2016
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
603

 
$
487

 
$
116

 
$
145

 
$
115

 
$
30

Embedded derivatives
 
7

 
2

 
5

 
9

 
2

 
7

Interest rate swaps(2)
 
7

 
7

 

 
45

 
45

 

TOTAL
 
$
617

 
$
496

 
$
121

 
$
199

 
$
162

 
$
37

(1)
If the foreign exchange derivative instruments had been netted in the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $136 million as of May 31, 2016. As of that date, the Company had received $105 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2016.
(2)
As of May 31, 2016, no amount of cash collateral had been received or posted on the derivative asset and liability balances related to its interest rate swap
The following table presents the fair values of derivative instruments included within the Consolidated Balance Sheets as of May 31, 2017 and 2016: 
 
 
Asset Derivatives
 
Liability Derivatives
(In millions)
 
Balance Sheet
Location
 
2017
 
2016
 
Balance Sheet 
Location
 
2017
 
2016
Derivatives formally designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
$
113

 
$
447

 
Accrued liabilities
 
$
59

 
$
38

Interest rate swaps
 
Prepaid expenses and other current assets
 

 
7

 
Accrued liabilities
 

 
45

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
13

 
90

 
Deferred income taxes and other liabilities
 
73

 
12

Interest rate swaps
 
Deferred income taxes and other assets
 

 

 
Deferred income taxes and other liabilities
 

 

Total derivatives formally designated as hedging instruments
 
 
 
126

 
544

 
 
 
132

 
95

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
103

 
40

 
Accrued liabilities
 
107

 
76

Embedded derivatives
 
Prepaid expenses and other current assets
 
1

 
2

 
Accrued liabilities
 
2

 
2

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
2

 
26

 
Deferred income taxes and other liabilities
 
7

 
19

Embedded derivatives
 
Deferred income taxes and other assets
 
9

 
5

 
Deferred income taxes and other liabilities
 
6

 
7

Total derivatives not designated as hedging instruments
 
 
 
115

 
73

 
 
 
122

 
104

TOTAL DERIVATIVES
 
 
 
$
241

 
$
617

 
 
 
$
254

 
$
199